Drug interactions
Echothiophate iodide + Ipratropium-salbutamol
Severity: Minor
Echothiophate iodide and Ipratropium-salbutamol: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Echothiophate is an irreversible cholinesterase inhibitor given as eye drops, and ipratropium is a muscarinic antagonist, so they have opposing effects. Systemic exposure from the eye drops is small, so the interaction is usually minor. Echothiophate can still cause bronchospasm or bradycardia in susceptible patients.
What this interaction means in plain words
Echothiophate iodide and Ipratropium-salbutamol have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Why it happens
Pharmacodynamic antagonism between cholinesterase inhibition and muscarinic blockade.
What to do
Monitor respiratory status and heart rate in patients with asthma or COPD receiving echothiophate.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Echothiophate iodide and Ipratropium-salbutamol, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Ipratropium-salbutamol
Frequently asked questions
Can I take Echothiophate iodide with Ipratropium-salbutamol?
MediHelp rates the interaction as minor. Echothiophate iodide and Ipratropium-salbutamol have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Echothiophate is an irreversible cholinesterase inhibitor given as eye drops, and ipratropium is a muscarinic antagonist, so they have opposing effects. Systemic exposure from the eye drops is small, so the interaction is usually minor. Echothiophate can still cause bronchospasm or bradycardia in susceptible patients.
How serious is the interaction between Echothiophate iodide and Ipratropium-salbutamol?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor respiratory status and heart rate in patients with asthma or COPD receiving echothiophate.
What other medicines interact with Ipratropium-salbutamol?
MediHelp also lists interactions of Ipratropium-salbutamol with, for example, Amisulpride, Arsenic trioxide, Carvedilol. The full list is on the Ipratropium-salbutamol page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
